Orient Europharma (Taiwan) Probability of Future Stock Price Finishing Over 48.1
| 4120 Stock | TWD 48.75 0.60 1.25% |
Orient |
Orient Europharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Orient Europharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Orient Europharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Orient Europharma has high likelihood to experience some financial distress in the next 2 years | |
| About 65.0% of the company shares are owned by insiders or employees |
Orient Europharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Orient Stock often depends not only on the future outlook of the current and potential Orient Europharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Orient Europharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 86.7 M |
Orient Europharma Technical Analysis
Orient Europharma's future price can be derived by breaking down and analyzing its technical indicators over time. Orient Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Orient Europharma Co. In general, you should focus on analyzing Orient Stock price patterns and their correlations with different microeconomic environments and drivers.
Orient Europharma Predictive Forecast Models
Orient Europharma's time-series forecasting models is one of many Orient Europharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Orient Europharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Orient Europharma
Checking the ongoing alerts about Orient Europharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Orient Europharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Orient Europharma has high likelihood to experience some financial distress in the next 2 years | |
| About 65.0% of the company shares are owned by insiders or employees |
Additional Tools for Orient Stock Analysis
When running Orient Europharma's price analysis, check to measure Orient Europharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Europharma is operating at the current time. Most of Orient Europharma's value examination focuses on studying past and present price action to predict the probability of Orient Europharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Europharma's price. Additionally, you may evaluate how the addition of Orient Europharma to your portfolios can decrease your overall portfolio volatility.